Entresto 24 MG-26 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA2T3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,947
Award facts
- Contract value 100% obligated
- $14,947.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,947.26 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units). This firm fixed-price, non-set-aside contract was awarded on January 16, 2026, with an ultimate completion date of January 20, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026, which enables the company to deliver a broad portfolio of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc., both of which serve as critical vendors in the federal medical procurement supply chain. The company's federal contracting demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, including cardiovascular treatments such as Entresto. The underlying indefinite delivery contract with DLA Troop Support Medical serves military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, reflecting the essential role pharmaceutical prime vendors play in supporting military medical readiness and veteran healthcare delivery.
Quick answers
Who was awarded contract SPE2DR26FA2T3?
SPE2DR26FA2T3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FA2T3 worth?
The government has obligated $14,947 on SPE2DR26FA2T3.
Is contract SPE2DR26FA2T3 an order under another contract?
Yes. SPE2DR26FA2T3 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2T3 competed?
The extent of competition for SPE2DR26FA2T3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award